AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11182048
Drug: alphaD3 (1alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alphaD3 (1alpha (OH) D3) administered to 18 patients
Trial: 9297265
Drug: Transdermal nitroglycerine
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerine (Nitroderm NNS 5)
Trial: 28275100
Drug: Small-Quantity Lipid-Based
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small-Quantity Lipid-Based Nutrient Supplements (SQ-LNSs; 20 g with 22 micronutrients/d)
Trial: 28275100
Drug: Iron and
RxNorm normalized name: beef,iron and wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron and Folic Acid (IFA; 60 mg Fe + 400 μg folic acid/d)
Trial: 28275100
Drug: Control (Placebo;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Placebo; 200 mg Ca/d)
Trial: 19276255
Drug: Weekly bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly bolus irinotecan, 5-fluorouracil, and leucovorin (IFL)
Trial: 19276255
Drug: Weekly bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly bolus 5-fluorouracil/leucovorin
Trial: 11306209
Drug: 17beta-estradiol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17beta-estradiol (1 mg/day) combined with dydrogesterone (5, 10 or 20 mg/day)
Trial: 2648510
Drug: Regime A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regime A: Rifampicin, Isoniazid, Streptomycin, Pyrazinamide for 2 months followed by Rifampicin and Isoniazid for 4 months (total 6 months treatment)
Trial: 31065839
Drug: Information booklet
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Information booklet about prostate cancer treatment options prior to biopsy
Trial: 19415543
Drug: Parathyroid hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Parathyroid hormone (PTH); specific dosage and duration not mentioned.
Trial: 11336078
Drug: Pilocarpine 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilocarpine 5.0 mg (1 cc) tid at meal times during radiation
Trial: 9130837
Drug: Long-term medication
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term medication
Trial: 7573830
Drug: loratadine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: loratadine (20 mg/day orally)
Trial: 25923680
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment with intraforaminal injection of steroid and anaesthetic
Trial: 20089783
Drug: Virgin Olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virgin Olive Oil (VOO) - 629 mg/L phenol concentration
Trial: 20089783
Drug: Refined Olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Refined Olive Oil (ROO) - 0 mg/L phenol concentration
Trial: 15853207
Drug: Drugs other
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs other than nitrosourea or drugs that reduce MGMT activity
Trial: 15853207
Drug: Targeting growth
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeting growth factor receptors such as EGFR or VEGFR
Trial: 8656422
Drug: Testosterone 2%
RxNorm normalized name: TESTOSTERONE 2% CREAM,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone 2% ointment
Trial: 8656422
Drug: Placebo cream-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream-based preparation
Trial: 1503133
Drug: Day treatment
RxNorm normalized name: Pharmacist Clotrimazole 3 Day Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Day treatment (experimental condition)
Trial: 6337763
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (140 gm) in divided doses over 12 hr
Trial: 6697647
Drug: Repeated oral
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated oral doses of activated charcoal
Trial: 18854201
Drug: Bolus isoproterenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus isoproterenol infusions
Trial: 16874208
Drug: Vacuum-assisted closure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vacuum-assisted closure therapy
Trial: 14974959
Drug: Conventional moist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional moist gauze therapy
Trial: 11166898
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of 90 microg rH5 vaccine
Trial: 29653390
Drug: Fondaparinux 2.5
RxNorm normalized name: FONDAPARINUX 2.5MG/0.5ML INJ SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux 2.5 mg daily (Group F)
Trial: 25302236
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (75 patients)
Trial: 16650054
Drug: Fluticasone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone (200 mcg) with levocetirizine
Trial: 3513346
Drug: Imipenem and
RxNorm normalized name: imipenem and cilastatin
DrugBank: Imipenem (DB01598)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Imipenem and cilastatin sodium 500 mg every six hours
Trial: 29261010
Drug: Chlorogenic acid
RxNorm normalized name: chlorogenic acid
DrugBank: Chlorogenic Acid (DB12029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorogenic acid (400 mg three times per day for 12 weeks)
Trial: 26892582
Drug: 100mcg vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100mcg vitamin K2 (MK7 subtype) daily for 6 months
Trial: 4059292
Drug: benserazide/l‐dopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benserazide/l‐dopa
Trial: 6399888
Drug: Amiloride 5
RxNorm normalized name: amiloride 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiloride 5 mg
Trial: 31981516
Drug: Riluzole 50
RxNorm normalized name: riluzole 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riluzole 50 mg
Trial: 24681228
Drug: 60 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 μg HB vaccine formulation
Trial: 24681228
Drug: 30 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 μg HB vaccine formulation
Trial: 24681228
Drug: 10 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 μg HB vaccine formulation
Trial: 16093465
Drug: Daily parathyroid
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily parathyroid hormone (1-34) subcutaneously
Trial: 10077715
Drug: Anthroposophical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthroposophical therapy
Trial: 10077715
Drug: Mainstream medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mainstream medicine (control group)
Trial: 31128485
Drug: Non-Traditional Chinese
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-Traditional Chinese Medicine (non-TCM)
Trial: 8511728
Drug: Salbutamol 0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol 0.5% solution by nebuliser
Trial: 29151179
Drug: Twelfth subcostal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twelfth subcostal nerve block with 10 ml lidocaine 2% + intramuscular diclofenac sodium 45 min before ESWL
Trial: 29151179
Drug: Twelfth subcostal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twelfth subcostal nerve block with 10 ml of lidocaine 2% + tramadol at 1 mg/Kg of weight, 45 min before ESWL
Trial: 26837628
Drug: Vaginal ring
RxNorm normalized name: NuvaRing Vaginal Ring
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal ring containing dapivirine, maraviroc, or both drugs for 28 days
Trial: 23732051
Drug: Flucloxacillin 500
RxNorm normalized name: cloxacillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flucloxacillin 500 mg four times daily (monotherapy)
Trial: 23732051
Drug: Flucloxacillin 500
RxNorm normalized name: cloxacillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flucloxacillin 500 mg four times daily and phenoxymethylpenicillin 500 mg four times daily (dual therapy)
Trial: 18378520
Drug: Ramipril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (10 mg per day)
Trial: 18378520
Drug: Telmisartan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (80 mg per day)
Trial: 8311283
Drug: 3% gelatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% gelatin in electrolyte solution
Trial: 24351518
Drug: NSAID therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAID therapy
Trial: 31563386
Drug: Sham taping
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham taping with NSAID therapy
Trial: 27154871
Drug: Modified Qing'e
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Qing'e Pill (MQEP)
Trial: 27992268
Drug: CHOP chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CHOP chemotherapy
Trial: 10845730
Drug: Placebo to
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo to Levetiracetam 4000 mg daily
Trial: 10845730
Drug: Levetiracetam 2000
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam 2000 mg daily (initiated)
Trial: 10845730
Drug: Open-label phase
RxNorm normalized name: strontium chloride, 89Sr-labeled
DrugBank: Strontium chloride Sr-89 (DB09498)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label phase (Levetiracetam 4000 mg daily)
Trial: 3513587
Drug: Progesterone vaginal
RxNorm normalized name: progesterone Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone vaginal suppositories (200 mg in polyethylene glycol base), self-administered twice daily for a minimum of 12 days before menstruation for 3 months
Trial: 3513587
Drug: Placebo, self-administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, self-administered twice daily for a minimum of 12 days before menstruation for 3 months
Trial: 22704229
Drug: Tranexamic Acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic Acid (TNA) administered preoperatively (1 g 10 minutes before surgery)
Trial: 22704229
Drug: Tranexamic Acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic Acid (TNA) administered postoperatively
Trial: 22704229
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no TNA administration)
Trial: 14989442
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (iNO) at 5 ppm
Trial: 11897289
Drug: Qualitative descriptions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qualitative descriptions of drug side-effects
Trial: 11897289
Drug: Quantitative descriptions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quantitative descriptions of drug side-effects
Trial: 14980334
Drug: Prochlorperazine 10
RxNorm normalized name: prochlorperazine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prochlorperazine 10 mg i.v.
Trial: 9660282
Drug: Ketorolac 30
RxNorm normalized name: ketorolac 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 30 mg i.v.
Trial: 8073244
Drug: Hypnosis administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypnosis administered by nurses
Trial: 8073244
Drug: Conventional oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional oral medication combined with nerve blocks and/or spinal administration of drugs
Trial: 2817597
Drug: LY171883 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY171883 600 mg twice a day
Trial: 4901346
Drug: Ferro-Gradume (slow-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferro-Gradume (slow-release preparation of ferrous sulphate)
Trial: 28325784
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 1,100 mg myo‐inositol, 27.6 mg D‐chiro‐inositol, and 400 μg folic acid
Trial: 28325784
Drug: 400 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 μg folic acid only
Trial: 16984988
Drug: Octreotide LAR
RxNorm normalized name: octreotide LAR 20 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide LAR (20 mg)
Trial: 16972594
Drug: Standard (basic)
RxNorm normalized name: Stangard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard (basic) therapy
Trial: 8742957
Drug: rHuEpo therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEpo therapy during dialysis
Trial: 31889508
Drug: Daily multiple
RxNorm normalized name: Daily Multiple Vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily multiple micronutrient powders (MNP; 10 mg zinc, 6 mg iron, and 13 other micronutrients)
Trial: 24972577
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine (CM) decoction based on syndrome differentiation
Trial: 17894656
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (20 mg/kg/day)
Trial: 2593866
Drug: Topical 17
RxNorm normalized name: salicylic acid topical 17% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 17 beta-oestradiol (E2) applied twice daily for 45-50 days at concentrations of 0.1 mg/g and 1.0 mg/g
Trial: 2593866
Drug: Placebo applied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo applied twice daily for 45-50 days
Trial: 23990646
Drug: Behavioral activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral activation treatment for depression (BATD)
Trial: 30925498
Drug: Add-on citalopram
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Add-on citalopram (30 mg/d)
Trial: 25758426
Drug: Partially hydrolyzed
RxNorm normalized name: Human Skin Proteins, Partially Hydrolyzed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partially hydrolyzed whey formula with L reuteri (PRO)
Trial: 25758426
Drug: Partially hydrolyzed
RxNorm normalized name: Human Skin Proteins, Partially Hydrolyzed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partially hydrolyzed whey formula without L reuteri (CON)
Trial: 15037526
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (100 mg/d)
Trial: 10348415
Drug: New therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New therapy
Trial: 16272869
Drug: Standard antituberculous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antituberculous chemotherapy for 6 or 12 months
Trial: 2405506
Drug: HCG injections
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCG injections and Placebo injections
Trial: 6159391
Drug: Somatostatin (0.025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin (0.025 mg/h)
Trial: 30307720
Drug: Conventional dental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dental implants
Trial: 19075276
Drug: Low-dose 13-cis
RxNorm normalized name: 13-cis-retinoic acid
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dose 13-cis retinoic acid (13cRA)
Trial: 7904106
Drug: Calcipotriol ointment
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol ointment (50 micrograms/g)
Trial: 9158266
Drug: Coal tar/2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coal tar/2% allantoin/0.5% hydrocortisone cream
Trial: 3284406
Drug: Buprenorphine (0.008
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (0.008 mg/kg)
Trial: 3284406
Drug: Morphine (0.333
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.333 mg/kg)
Trial: 11475719
Drug: Ticlid 250
RxNorm normalized name: Ticlid 250mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlid 250 mg orally, once a day
Trial: 11475719
Drug: Panax notoginseng
RxNorm normalized name: PANAX NOTOGINSENG TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Panax notoginseng (PNG) 8 ml in 250 ml of normal saline intravenous drip once a day
Trial: 2612535
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal 16 g/day
Trial: 2612535
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal 32 g/day
Trial: 2612535
Drug: Cholestyramine 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine 16 g
Trial: 26042589
Drug: Tildrakizumab 5
RxNorm normalized name: Tildrakizumab
DrugBank: Tildrakizumab (DB14004)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tildrakizumab 5 mg
Trial: 22375409
Drug: Kangai injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kangai injection plus FLAG regimen
Trial: 19114859
Drug: Injections in
RxNorm normalized name: Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injections in the previous 3 months
Trial: 14557887
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment for infections, allergies, gastroesophageal reflux, and environmental irritants.
Trial: 24095300
Drug: Trastuzumab (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab (4 mg/kg load, then 2 mg/kg intravenously weekly until surgery)
Trial: 24095300
Drug: Lapatinib (1250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib (1250 mg orally daily until surgery)
Trial: 24095300
Drug: Weekly trastuzumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly trastuzumab plus lapatinib (750 mg orally daily until surgery)
Trial: 15153818
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of fibrin (Group 2)
Trial: 10955016
Drug: CSE inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSE inhibitors
Trial: 8636309
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg finasteride daily for 6-18 days (group 1)
Trial: 8423429
Drug: Chiropractic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiropractic treatment including side-lying manipulation (n = 17)
Trial: 3616852
Drug: Ceftriaxone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (2 g im daily for two days)
Trial: 3616852
Drug: Ceftriaxone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (2 g im daily for five days)
Trial: 3616852
Drug: Benzathine penicillin
RxNorm normalized name: Benzathine penicillin G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzathine penicillin (2.4 X 10(6) units in a single im injection)
Trial: 23560500
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg oral gabapentin
Trial: 24079752
Drug: Adjuvant S‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant S‐1 therapy
Trial: 3462014
Drug: Saline inhalation
RxNorm normalized name: Broncho Saline Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline inhalation
Trial: 12459670
Drug: Dyclonine inhalation
RxNorm normalized name: DYCLONINE
DrugBank: Dyclonine (DB00645)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dyclonine inhalation
Trial: 11374600
Drug: Ropivacaine inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine inhalation
Trial: 12459670
Drug: Lidocaine inhalation
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine inhalation
Trial: 9039247
Drug: Inhaled frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled frusemide (38.0 (6.4) mg, pH = 9)
Trial: 2899239
Drug: Inhaled frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled frusemide
Trial: 8381758
Drug: Morphine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (100 micrograms/kg iv)
Trial: 8381758
Drug: Naloxone (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.8 mg iv)
Trial: 9541446
Drug: Chloramphenicol eye
RxNorm normalized name: Chloramphenicol
DrugBank: Chloramphenicol succinate (DB07565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloramphenicol eye ointment
Trial: 29361468
Drug: Neoadjuvant plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant plus adjuvant dabrafenib and trametinib (8 weeks of neoadjuvant oral dabrafenib 150 mg twice per day and oral trametinib 2 mg per day followed by surgery, then up to 44 weeks of adjuvant dabrafenib plus trametinib starting 1 week after surgery for a total of 52 weeks of treatment)
Trial: 29361468
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care (upfront surgery and consideration for adjuvant therapy)